Royalty Pharma plc (RPRX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Royalty Pharma (RPRX) Q4 2025: Synthetic Royalties Hit 44% of Deals, Unlocking New Growth Channels
June 15, 2026
-
Royalty Pharma (RPRX) Q1 2026: R&D Co-Funding Surges to $1B, Unlocking New Growth Pathways
May 06, 2026
-
Royalty Pharma (RPRX) Q3 2025: $1.7B Deployed as Synthetic Royalties Expand Pipeline Depth
November 05, 2025
-
Royalty Pharma (RPRX) Q2 2025: Portfolio Receipts Up 20% as Synthetic Royalty Model Scales
August 06, 2025
-
Royalty Pharma (RPRX) Q1 2025: Share Repurchases Hit $723M as Portfolio Receipts Climb 17%
July 07, 2025